AfsanehShiraniMDMSCI

PubMed

• Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion.
  Afsaneh Shirani, Olaf Stuve, Anne H Cross> ;Neurologic Clinics. 2024 Feb 1
• Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.
  Anne H Cross, Afsaneh Shirani, Olaf Stuve> ;Therapeutic Advances in Neurological Disorders. 2024 Jan 1
• 1 citations
  Disseminated Aspergillosis in a Patient With Neurosarcoidosis: Persistent Contrast Enhancement in CNS Despite Prolonged Antifungal Treatment: A Case Report.
  Lakshman Arcot Jayagopal, Afsaneh Shirani, Kelly Cawcutt, Jie Chen, Ana Yuil-Valdes, Rana Zabad> ;Journal of Central Nervous System Disease. 2023 Jan 1
• 2 citations
  Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?
  Navnika Gupta, Afsaneh Shirani, Lakshman Arcot Jayagopal, Ezequiel Piccione, Elizabeth Hartman, Rana Khalil Zabad> ;Brain Sciences. 2022 Aug 24
• 2 citations
  Clinical trials in multiple sclerosis: past, present, and future.
  Navid Manouchehri, Afsaneh Shirani, Victor H Salinas, Lauren Tardo, Rehana Z Hussain, David Pitt, Olaf Stuve> ;Neurologia i Neurochirurgia Polska. 2022 Jan 1
• 2 citations
  It Is Time to Stop Racial Exclusion in Scholarly Citations.
  Afsaneh Shirani> ;Journal of Bioethical Inquiry. 2021 Oct 21
• Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report.
  Afsaneh Shirani, Scott R Dalton, Eric J Avery, Lakshman Arcot Jayagopal, Christina Meyer, Olaf Stüve, Rana Zabad> ;Journal of Central Nervous System Disease. 2021 Jan 1
• 22 citations
  Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
  Yinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Gary Cutter, William J. Culpepper, Mitchell T. Wallin, Peter Kosa, Bibiana Bielekova, Fred D. Lub...> ;Therapeutic Advances in Neurological Disorders. 2020 Oct 28
• 26 citations
  Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database.
  Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Olaf Stüve> ;Multiple Sclerosis. 2021 Jun 1
• 1 citations
  Handedness and potential implications for neurorehabilitation in multiple sclerosis.
  Afsaneh Shirani, Darin T. Okuda> ;Multiple Sclerosis and Related Disorders. 2020 Jan 1
• 12 citations
  Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report
  Afsaneh Shirani, Peng Sun, Robert E. Schmidt, Kathryn Trinkaus, Robert T. Naismith, Sheng-Kwei Song, Anne H. Cross> ;Multiple Sclerosis. 2019 Dec 1
• 14 citations
  Diffusion basis spectrum imaging for identifying pathologies in MS subtypes.
  Afsaneh Shirani, Peng Sun, Kathryn Trinkaus, Dana C. Perantie, Ajit George, Robert T. Naismith, Robert E. Schmidt, Sheng-Kwei Song, Anne H. Cross> ;Annals of Clinical and Translational Neurology. 2019 Nov 1
• 2 citations
  The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report.
  Afsaneh Shirani, Anne H. Cross, Robert T. Naismith> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019 Feb 26
• 11 citations
  Natalizumab: Perspectives from the Bench to Bedside.
  Afsaneh Shirani, Olaf Stüve> ;Cold Spring Harbor Perspectives in Medicine. 2018 Dec 1
• 8 citations
  Gender Inequities in the Multiple Sclerosis Community: A Call for Action
  Emmanuelle Waubant, Lilyana Amezcua, Nancy L. Sicotte, Kerstin Hellwig, Lauren B. Krupp, Bianca Weinstock-Guttman, Ann Yeh, Robyn M. Lucas, Erin E. Longbrake, Vijay Ya...> ;Annals of Neurology. 2018 Nov 30
• 5 citations
  A case of oligodendroglioma and multiple sclerosis: Occam’s razor or Hickam’s dictum?
  Afsaneh Shirani, Gregory F. Wu, Caterina Giannini, Anne H. Cross> ;BMJ Case Reports. 2018 Jun 28
• 34 citations
  Evaluating the safety of β-interferons in MS A series of nested case-control studies
  Hilda J. I. de Jong, Elaine Kingwell, Afsaneh Shirani, Jan Willem Cohen Tervaert, Raymond Hupperts, Yinshan Zhao, Feng Zhu, Charity Evans, Mia L. van der Kop, Anthony ...> ;Neurology. 2017 May 12
• 15 citations
  Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions.
  Afsaneh Shirani, Braeden D. Newton, Darin T. Okuda> ;BMC Neurology. 2017 Mar 21
• 19 citations
  Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology
  Afsaneh Shirani, Olaf Stüve> ;Journal of Immunology. 2017 Feb 15
• 12 citations
  Disability progression in aggressive multiple sclerosis.
  Suresh Menon, Feng Zhu, Afsaneh Shirani, Joel Oger, Mark S. Freedman, Helen Tremlett> ;Multiple Sclerosis. 2017 Mar 1
• 68 citations
  Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
  Afsaneh Shirani, Darin T. Okuda, Olaf Stüve> ;Neurotherapeutics. 2016 Jan 4
• 29 citations
  Beta-interferon exposure and onset of secondary progressive multiple sclerosis
  Tingting Zhang, Afsaneh Shirani, Yinshan Zhao, Mohammad Ehsanul Karim, Paul Gustafson, John Petkau, Charity Evans, Elaine Kingwell, M. van der Kop, Feng Zhu, Joel Oger...> ;European Journal of Neurology. 2015 Jun 1
• 33 citations
  Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
  Afsaneh Shirani, Yinshan Zhao, John Petkau, Paul Gustafson, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. van der Kop, Joel Oger, Helen Tremlett> ;Biomed Research International. 2015 Apr 1
• 9 citations
  Association between beta-interferon exposure and hospital events in multiple sclerosis.
  Charity Evans, Feng Zhu, Elaine Kingwell, Afsaneh Shirani, Mia L. van der Kop, John Petkau, Paul Gustafson, Yinshan Zhao, Joel Oger, Helen Tremlett> ;Pharmacoepidemiology and Drug Safety. 2014 Nov 1
• 54 citations
  Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort
  Mohammad Ehsanul Karim, Paul Gustafson, John Petkau, Yinshan Zhao, Afsaneh Shirani, Elaine Kingwell, Charity Evans, Mia L. van der Kop, Joel Oger, Helen Tremlett> ;American Journal of Epidemiology. 2014 Jul 15
• Join now to see all